ALIM - Alimera Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
52,081
46,970
35,912
34,333
Cost of Revenue
6,050
4,679
3,438
2,344
Gross Profit
46,031
42,291
32,474
31,989
Operating Expenses
Research Development
11,198
11,274
12,844
12,375
Selling General and Administrative
38,784
38,042
36,249
44,694
Total Operating Expenses
52,660
51,961
51,777
59,836
Operating Income or Loss
-6,629
-9,670
-19,303
-27,847
Interest Expense
4,931
4,776
5,579
5,178
Total Other Income/Expenses Net
-218
-1,831
3,044
23
Income Before Tax
-11,778
-16,277
-21,838
-33,002
Income Tax Expense
411
106
163
172
Income from Continuing Operations
-12,189
-16,383
-22,001
-33,174
Net Income
-12,189
-16,383
-22,001
-33,174
Net Income available to common shareholders
-7,527
21,947
-22,001
-33,174
Reported EPS
Basic
-
3.75
-4.95
-9.45
Diluted
-
3.75
-4.95
-9.45
Weighted average shares outstanding
Basic
-
4,667
4,466
3,520
Diluted
-
4,716
4,466
3,520
EBITDA
-
-8,856
-13,575
-25,057